D R Harper
Overview
Explore the profile of D R Harper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
939
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alves D, Gaudion A, Bean J, Perez Esteban P, Arnot T, Harper D, et al.
Appl Environ Microbiol
. 2014 Aug;
80(21):6694-703.
PMID: 25149517
Biofilms are major causes of impairment of wound healing and patient morbidity. One of the most common and aggressive wound pathogens is Staphylococcus aureus, displaying a large repertoire of virulence...
2.
Harper D, Anderson J, Enright M
Ther Deliv
. 2012 Jul;
2(7):935-47.
PMID: 22833904
Bacteriophages are viruses that infect and, in many cases, destroy their bacterial targets. Within a few years of their initial discovery they were being investigated as therapeutic agents for infectious...
3.
Harper D, Enright M
J Appl Microbiol
. 2011 Mar;
111(1):1-7.
PMID: 21410851
Bacteriophages were first identified in 1915 and were used as antimicrobial agents from 1919 onwards. Despite apparent successes and widespread application, early users did not understand the nature of these...
4.
Harper D
Methods Mol Med
. 2011 Feb;
24:119-27.
PMID: 21331904
Compared to the wide range of antibiotics that are available, the number of antiviral drugs is limited. However, herpesviruses have always been a major target for antiviral drug design, and...
5.
Monk A, Rees C, Barrow P, Hagens S, Harper D
Lett Appl Microbiol
. 2010 Aug;
51(4):363-9.
PMID: 20796209
Bacteriophages are bacterial viruses and have been used for almost a century as antimicrobial agents. In the West, their use diminished when chemical antibiotics were introduced, but they remain a...
6.
Wright A, Hawkins C, Anggard E, Harper D
Clin Otolaryngol
. 2009 Aug;
34(4):349-57.
PMID: 19673983
Objectives: To evaluate the efficacy and safety of a therapeutic bacteriophage preparation (Biophage-PA) targeting antibiotic-resistant Pseudomonas aeruginosa in chronic otitis. Design: Randomised, double-blind, placebo-controlled Phase I/II clinical trial approved by...
7.
Harper D, Davies L, Gadd E, Costigan S
J Public Health (Oxf)
. 2008 Jul;
30(4):373-4.
PMID: 18603626
Authoratative government pandemic preparedness requires an evidence-based approach. The scientific advisory process that has informed the current UK pandemic preparedness plans is described. The final endorsed scientific papers are now...
8.
Patel R, Harper D
Curr Opin Infect Dis
. 2006 Oct;
11(1):31-5.
PMID: 17033364
Although there has been considerable refinement in our understanding of the processes underlying the establishment and maintenance of latency, important research questions remain. Results from various workers imply that the...
9.
Ruckley C, Callam M, Harper D, Dale J, Gibson B, Prescott R
Br J Surg
. 2002 May;
89(6):810; author reply 810.
PMID: 12028005
No abstract available.
10.
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E
Hasan U, Harper D, Wren B, Morrow W
Vaccine
. 2002 Jan;
20(9-10):1308-15.
PMID: 11818149
The gE glycoprotein of varicella zoster virus (VZV) is involved with cell entry and it is the most abundant glycoprotein produced in VZV-infected cells. It is also the first glycoprotein...